NCT00523939View on ClinicalTrials.gov

DepoCyt for Active Lymphomatous or Leukemic Meningitis

PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Neoplastic MeningitisLymphoma, B Cell
Interventions
DRUG

cytarabine liposome injection

50 mg intrathecal every 14 days for 8 doses, then every 28 days for six doses

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

Enzon Pharmaceuticals, Inc.

INDUSTRY

lead

Duke University

OTHER